UoN Lecturer Sobbie Mulindi Succumbs to Cancer.

    Dr Sobbie Mulindi
    Dr Sobbie Mulindi

    Dr. Sobbie Mulindi, a Consultant Psychiatrist and Prominent Aids Researcher die of Cancer on Tuesday, 6 August at the age of 70 years.

    He has been battling cancer since 2017. However, the type of cancer he has been suffering from and the course of treatment has not been revealed.

    Dr. Mulindi was the Former Deputy Director of the National Air Control Council, serving for 6 years from 2008-2014, and also a senior lecturer in the Psychiatry department of the University of Nairobi.

    He will surely be remembered for his several achievements including helping to reduce the HIV prevalence rate from a high of 30% in the early 2000s.

    He constantly educated and warned youths against unprotected sex and consequently spoke frankly and openly about the correlation between sex and HIV-AIDs.

    In his work, Renowned Aids Researcher was heavily involved in the preparation of the Sessional Paper No. 4 on HIV-Aids in and also wrote “HIV/AIDS Situation Analysis” for the Ministry of Health which greatly helped in facilitating the development of its strategic plan on HIV and AIDS.

    Dr. Mulindi has been involved in the development of subsequent Four Natural Strategic Plans for HIV/AIDs prevention in Kenya and other countries including South Africa, Swaziland, Rwanda, Benin, Somali, Congo, and Brazzaville.

    In 2013, Dr. Sobbie Mulindi was a team leader that facilitated and launched the First Lady’s agenda towards Zero Campaign.

    Among the many other prominent members of the public who have recently died of cancer are Safaricom Chief Executive Officer Bob Collymore, Bomet Governor Joyce Laboso and Kibira Member of Parliament Ken Okoth.

    The country continues to mourn these members of the public among others who die of cancer as the Governors request the President of the Republic of Kenya Uhuru Kenyatta to declare Cancer a National Disaster.

    Facebook Comments
    Please follow and like us:
    error

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here